Is LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Recent Stock Performance Tethered To Its Strong Fundamentals?
Is LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Recent Stock Performance Tethered To Its Strong Fundamentals?
LBX Pharmacy Chain (SHSE:603883) has had a great run on the share market with its stock up by a significant 11% over the last month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. In this article, we decided to focus on LBX Pharmacy Chain's ROE.
LBX Pharmacy Chain公司(SHSE: 603883)在股市上表现良好,其股票比上个月大幅上涨了11%。鉴于从长远来看,市场会奖励强劲的财务状况,我们想知道在这种情况下是否如此。在本文中,我们决定重点关注LBX药房连锁店的投资回报率。
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.
投资回报率或股本回报率是评估公司如何有效地从股东那里获得投资回报的有用工具。简而言之,投资回报率显示了每美元从其股东投资中产生的利润。
How Is ROE Calculated?
ROE 是如何计算的?
The formula for ROE is:
ROE 的公式是:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
股本回报率 = 净利润(来自持续经营业务)÷ 股东权益
So, based on the above formula, the ROE for LBX Pharmacy Chain is:
因此,根据上述公式,LBX 药房连锁店的投资回报率为:
15% = CN¥1.1b ÷ CN¥7.3b (Based on the trailing twelve months to September 2023).
15% = 人民币1.1亿元/人民币7.3亿元人民币(基于截至2023年9月的过去十二个月)。
The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every CN¥1 worth of equity, the company was able to earn CN¥0.15 in profit.
“回报” 是指公司去年的收益。另一种看法是,每持有价值1元人民币的股权,公司就能获得0.15元人民币的利润。
What Has ROE Got To Do With Earnings Growth?
投资回报率与收益增长有什么关系?
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
我们已经确定,投资回报率是衡量公司未来收益的有效盈利指标。根据公司选择将多少利润进行再投资或 “保留”,我们便能够评估公司未来创造利润的能力。假设其他一切保持不变,那么与不一定具有这些特征的公司相比,投资回报率和利润保留率越高,公司的增长率就越高。
LBX Pharmacy Chain's Earnings Growth And 15% ROE
LBX 连锁药店的收益增长和 15% 的投资回报率
To begin with, LBX Pharmacy Chain seems to have a respectable ROE. Especially when compared to the industry average of 8.4% the company's ROE looks pretty impressive. Probably as a result of this, LBX Pharmacy Chain was able to see a decent growth of 14% over the last five years.
首先,LBX连锁药房似乎具有可观的投资回报率。特别是与行业平均水平的8.4%相比,该公司的投资回报率看起来相当可观。可能是由于这个原因,LBX药房连锁店在过去五年中得以实现14%的可观增长。
Next, on comparing LBX Pharmacy Chain's net income growth with the industry, we found that the company's reported growth is similar to the industry average growth rate of 13% over the last few years.
接下来,在将LBX Pharmacy Chain的净收入增长与该行业的净收入增长进行比较时,我们发现该公司报告的增长与过去几年13%的行业平均增长率相似。
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). Doing so will help them establish if the stock's future looks promising or ominous. Is LBX Pharmacy Chain fairly valued compared to other companies? These 3 valuation measures might help you decide.
为公司附加价值的基础在很大程度上与其收益增长息息相关。对于投资者来说,重要的是要知道市场是否对公司的预期收益增长(或下降)进行了定价。这样做将帮助他们确定股票的未来是乐观还是不祥的。与其他公司相比,LBX药房连锁店的估值是否合理?这3种估值指标可能会帮助您做出决定。
Is LBX Pharmacy Chain Using Its Retained Earnings Effectively?
LBX连锁药房是否有效地使用了其留存收益?
LBX Pharmacy Chain has a three-year median payout ratio of 30%, which implies that it retains the remaining 70% of its profits. This suggests that its dividend is well covered, and given the decent growth seen by the company, it looks like management is reinvesting its earnings efficiently.
LBX Pharmacy Chain的三年派息率中位数为30%,这意味着它保留了剩余的70%的利润。这表明其股息覆盖范围良好,鉴于该公司的可观增长,管理层似乎正在有效地对其收益进行再投资。
Besides, LBX Pharmacy Chain has been paying dividends over a period of eight years. This shows that the company is committed to sharing profits with its shareholders. Our latest analyst data shows that the future payout ratio of the company over the next three years is expected to be approximately 32%. As a result, LBX Pharmacy Chain's ROE is not expected to change by much either, which we inferred from the analyst estimate of 15% for future ROE.
此外,LBX药房连锁店已经在八年内派发了股息。这表明该公司致力于与股东分享利润。我们的最新分析师数据显示,公司未来三年的派息率预计约为32%。因此,预计LBX药房连锁店的投资回报率也不会有太大变化,我们从分析师对未来投资回报率为15%的估计中推断了这一点。
Conclusion
结论
On the whole, we feel that LBX Pharmacy Chain's performance has been quite good. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. That being so, the latest analyst forecasts show that the company will continue to see an expansion in its earnings. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
总的来说,我们认为LBX药房连锁店的表现相当不错。特别是,很高兴看到该公司正在对其业务进行大量投资,再加上高回报率,这为其收益带来了可观的增长。既然如此,分析师的最新预测显示,该公司的收益将继续增长。要了解有关公司未来收益增长预测的更多信息,请查看这份免费的分析师预测报告,以了解更多信息。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。